NAT9

NAT9
Identifiers
Aliases	NAT9, EBSP, hNATL, N-acetyltransferase 9 (putative)
External IDs	MGI: 1913426; HomoloGene: 9231; GeneCards: NAT9; OMA:NAT9 - orthologs
Gene location (Human)
Chr.	Chromosome 17 (human)
End	74,776,367 bp
Gene location (Mouse)
Chr.	Chromosome 11 (mouse)
End	115,187,859 bp
RNA expression pattern
	Top expressed in
	anterior pituitary; ; right adrenal gland; ; left adrenal cortex; ; right adrenal cortex; ; right ovary; ; left ovary; ; right hemisphere of cerebellum; ; right lobe of thyroid gland; ; left lobe of thyroid gland; ; canal of the cervix;
	Top expressed in
	spermatocyte; ; seminiferous tubule; ; granulocyte; ; spermatid; ; neural layer of retina; ; right kidney; ; muscle of thigh; ; yolk sac; ; proximal tubule; ; left lobe of liver;
	More reference expression data
	More reference expression data
Gene ontology
Molecular function	transferase activity; acyltransferase activity; protein binding; acyltransferase activity, transferring groups other than amino-acyl groups; N-acetyltransferase activity;
Cellular component	protein-containing complex;
Biological process	N-terminal protein amino acid acetylation; protein acetylation;
	Sources:Amigo / QuickGO
Orthologs
	26151
	66176
	ENSG00000109065
	ENSMUSG00000015542
	Q9BTE0
	Q3UG98
NM_001305077; NM_001305078; NM_001305079; NM_001305080; NM_001305081;
	NM_001305082; NM_001305083; NM_001305084; NM_001305085; NM_001305086; NM_001305087; NM_001305088; NM_015654
	NM_025400
NP_001292006; NP_001292007; NP_001292008; NP_001292009; NP_001292010;
	NP_001292011; NP_001292012; NP_001292013; NP_001292014; NP_001292015; NP_001292016; NP_001292017; NP_056469
	NP_079676; NP_001349818; NP_001349819; NP_001349820; NP_001349821
	Wikidata
View/Edit Human	View/Edit Mouse

N-acetyltransferase 9 is an enzyme that in humans is encoded by the NAT9 gene.^[5]^[6]

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000109065 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000015542 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM (Dec 2003). "A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis". Nat Genet. 35 (4): 349–56. doi:10.1038/ng1268. PMID 14608357. S2CID 22368199.
^ "Entrez Gene: NAT9 N-acetyltransferase 9".

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000109065 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000015542 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid14608357-5] Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM (Dec 2003). "A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis". Nat Genet. 35 (4): 349–56. doi:10.1038/ng1268. PMID 14608357. S2CID 22368199.

[entrez-6] "Entrez Gene: NAT9 N-acetyltransferase 9".

[1]

[2]

[3]

[4]

[5]

[6]